SEC Form 4 · accession 0001209191-19-011541
Myovant Sciences Ltd. · MYOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ferreira Juan Camilo Arjona
Officer — Chief Medical Officer
Period of report
Feb 15, 2019
Accepted (ET)
Feb 20, 2019 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001679082
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 15, 2019 | S | 260 | $21.15 | D | 9,740 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.